Advanced search
Publication Cover
Clinical Toxicology Volume 52, 2014 - Issue 6
Submit an article Journal homepage
1,507
Views
17
CrossRef citations to date
0
Altmetric
Letters to the Editor

Cardiac arrest after ibogaine ingestion

L. VlaanderenDepartment of Emergency Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The NetherlandsCorrespondence[email protected]
,
L. C. MartialDepartment of Clinical Pharmacy, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands
,
E. J. F. FranssenDepartment of Clinical Pharmacy, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands
,
P. H. J. van der VoortDepartment of Intensive Care, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands
,
E. OosterwerffDepartment of Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands
&
G. A. SomsenDepartment of Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands
Pages 642-643 | Received 25 Nov 2013, Accepted 15 May 2014, Published online: 18 Jun 2014

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ruud P. W. Litjens & Tibor M. Brunt. (2016) How toxic is ibogaine?. Clinical Toxicology 54:4, pages 297-302.
Read now

Articles from other publishers (16)

Boukandou Mounanga Marlaine Michele & Aboughe Angone Sophie. (2023) A review of the mechanisms involved in the neuroprotection and neurotoxicity of Iboga alkaloids. Pharmacological Research - Natural Products 1, pages 100006.
Crossref
Juliana Mendes Rocha, José A. S. Reis, José Carlos Bouso, Jaime E. C. Hallak & Rafael G. dos Santos. (2023) Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies. European Archives of Psychiatry and Clinical Neuroscience.
Crossref
Genís Ona, Juliana Mendes Rocha, José Carlos Bouso, Jaime E. C. Hallak, Tre Borràs, Maria Teresa Colomina & Rafael G. dos Santos. (2021) The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020). Psychopharmacology 239:6, pages 1977-1987.
Crossref
James Grogan, Roy Gerona, Jerry W. Snow & Louise Kao. (2019) Ibogaine Consumption With Seizure-Like Episodes, QTc-Prolongation, and Captured Cardiac Dysrhythmias. The Journal of Emergency Medicine 57:4, pages e99-e104.
Crossref
Michael J. Wasko, Paula A. Witt-Enderby & Christopher K. Surratt. (2018) DARK Classics in Chemical Neuroscience: Ibogaine. ACS Chemical Neuroscience 9:10, pages 2475-2483.
Crossref
John Martin Corkery. 2018. Psychedelic Neuroscience. Psychedelic Neuroscience 217 257 .
Lena Rubi, Daniel Eckert, Stefan Boehm, Karlheinz Hilber & Xaver Koenig. (2016) Anti-addiction Drug Ibogaine Prolongs the Action Potential in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Cardiovascular Toxicology 17:2, pages 215-218.
Crossref
Lauren K. Shawn. 2017. Case Studies in Medical Toxicology. Case Studies in Medical Toxicology 227 234 .
L.J. Schep, R.J. Slaughter, S. Galea & D. Newcombe. (2016) Ibogaine for treating drug dependence. What is a safe dose?. Drug and Alcohol Dependence 166, pages 1-5.
Crossref
M Belgers, M Leenaars, J R Homberg, M Ritskes-Hoitinga, A F A Schellekens & C R Hooijmans. (2016) Ibogaine and addiction in the animal model, a systematic review and meta-analysis. Translational Psychiatry 6:5, pages e826-e826.
Crossref
Catherine Hildyard, Philip Macklin, Bernard Prendergast & Yaver Bashir. (2016) A Case of QT Prolongation and Torsades de Pointes Caused by Ibogaine Toxicity. The Journal of Emergency Medicine 50:2, pages e83-e87.
Crossref
Madalee M. Gassaway, Teresa L. Jacques, Andrew C. Kruegel, Richard J. KarpowiczJr.Jr., Xiaoguang Li, Shu Li, Yves Myer & Dalibor Sames. (2015) Deconstructing the Iboga Alkaloid Skeleton: Potentiation of FGF2-induced Glial Cell Line-Derived Neurotrophic Factor Release by a Novel Compound . ACS Chemical Biology 11:1, pages 77-87.
Crossref
Kenneth Alper, Rong Bai, Nian Liu, Steven J. Fowler, Xi-Ping Huang, Silvia G. Priori & Yanfei Ruan. (2015) hERG Blockade by Iboga Alkaloids. Cardiovascular Toxicology 16:1, pages 14-22.
Crossref
Fabrizio Schifano, Laura Orsolini, G. Duccio Papanti & John M. Corkery. (2015) Novel psychoactive substances of interest for psychiatry. World Psychiatry 14:1, pages 15-26.
Crossref
Xaver Koenig & Karlheinz Hilber. (2015) The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation. Molecules 20:2, pages 2208-2228.
Crossref
. (2014) Ibogaine abuse. Reactions Weekly 1518:1, pages 94-94.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.